Lifeward launches ReWalk 7 exoskeleton sales in the U.S. - 2025-04-15 - Product Launch - Lifeward launched U.S. sales of the ReWalk 7 personal exoskeleton. The launch followed FDA clearance in March 2025. The product is used to support standing and walking for individuals with spinal cord injury. - source: ir.rewalk.com
Lifeward receives FDA clearance for ReWalk 7 exoskeleton - 2025-03-13 - Regulatory - Lifeward received 510(k) FDA clearance for the ReWalk 7 personal exoskeleton. The seventh-generation ReWalk device is designed for individuals with spinal cord injury. The clearance followed prior FDA clearance for ReWalk stair and… - source: ir.rewalk.com